Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

News

From left to right: Professor Timothy Behrens; Professor Andrew Goodwin and Professor Andrea Vedaldi

Exceptional Oxford researchers awarded first Royal Society Faraday Discovery Fellowships

Three pioneering Oxford researchers are among the first recipients of the Royal Society Faraday Discovery Fellowships, prestigious long-term awards to support exceptional mid-career research leaders in the UK. Only seven academics were selected in total from more than 600 initial applications.

From left to right: Professor Kayla King; Professor Michael Wooldridge (photo credit: Paul Wilkinson); Professor Philipp Kukura; Professor Rory Collins

Four Oxford researchers recognised in the 2025 Royal Society Awards

The annual Royal Society Awards recognise exceptional research achievements through a series of prestigious medals and prizes. Of the 27 awards for 2024-25, announced today, four honour Oxford University researchers for their outstanding contributions to scientific discovery, public engagement and research culture.

OrganOx device

Oxford University spinout OrganOx to be acquired by Terumo for a record $1.5bn

An agreement has been reached for the acquisition of OrganOx, a pioneering University of Oxford spinout transforming kidney and liver transplantation, by Terumo Corporation, a global medical technology company headquartered in Tokyo, Japan, for US$1.5 billion. The transaction, which is subject to regulatory and other approvals, would be the largest acquisition of an Oxford University spinout to date, and one of the most significant venture capital exits in UK university spinout history.

Digital illustration of the new site. A big building with several floors and lots of glass windows next to the current Warneford Hospital building.

Planning application submitted for a major mental health and medical research campus in Oxford

Plans to transform an NHS site into a major mental health and medical research campus in Headington have been submitted to Oxford City Council by Oxford Health NHS Foundation Trust.

Large woman's eye before an eye test machine

Oxford researchers develop uniquely shaped microstent to combat glaucoma

A team of researchers at the University of Oxford have unveiled a pioneering ‘microstent’ which could revolutionise treatment for glaucoma, a common but debilitating condition. The study has been published in The Innovation, Cell Press.

Chronic pain research breakthrough identifies promising drug target

For the first time, a team of researchers have identified a new genetic link to pain, offering a promising drug target to alleviate chronic pain.

Using AI to reclassify multiple sclerosis progression

Researchers in the Big Data Institute at the University of Oxford, together with MS experts from ten leading institutions across the world and drug developers from Novartis and Roche, have collaborated to develop an artificial intelligence (AI) model for reclassifying the progression of multiple sclerosis (MS). This model is based on the largest collection of clinical trial data (Novartis-Oxford MS dataset) from people living with MS.

daLUXendins can be visualized using fluorescence microscopy to pinpoint GLP1R and GIPR binding and activation. This is shown in the periphery (islet of Langerhans in the pancreas, left) and centrally (hypothalamus in the brain, right) where daLUXendins act to drive insulin secretion and to control appetite, respectively.

Scientists reveal how new diabetes and obesity drugs work

A team led by scientists at the University of Oxford and the Leibniz-Forschungsinstitut für Molekulare Pharmakologie in Berlin has used fluorescent versions of next-generation diabetes and obesity drugs to reveal, for the first time, exactly which cells they target in the pancreas and brain.

Young African woman walking with her baby, Kenya

Study finds giving pregnant women cash transfers cuts infant mortality in half

A new study by Associate Professor Dennis Egger (Department of Economics and Centre for the Study of African Economies, University of Oxford) and researchers at the University of California, Berkeley reveals that giving unconditional cash transfers to pregnant women in rural Kenya significantly reduces infant and child mortality.

Healthcare worker vaccinating a woman

First volunteers receive Rift Valley fever vaccine in Kenya Phase II trial

On 8 July 2025, researchers at the KEMRI-Wellcome Trust Research Programme began the Phase II trial of the ChAdOx1 RVF vaccine in Kilifi, Kenya—the most advanced Rift Valley fever vaccine study in an outbreak-prone region. Led by Oxford University and funded by CEPI, this milestone brings us closer to a licensed vaccine for protecting lives and livelihoods.

Microsopy image showing DNA inside platelets.

Platelets Shown to Store DNA in Study that could Transform Cancer Screening

Study led by Psaila Group uncovers previously unknown function of platelets as DNA ‘vacuum cleaners’ in the blood, with profound implications for cancer diagnosis and prenatal screening.

Severe nurse shortages in Kenya undermine newborn care, despite advancements

A multi-disciplinary study by KEMRI-Wellcome Trust, Harnessing Innovation in Global Health for Quality Care (HIGH-Q), has revealed how workforce issues influence the quality of care in newborn units. The research highlighted the effect of severe nurse staffing shortages in Kenyan hospitals as a major obstacle to providing quality care for newborns.

A close up of the hands of a doctor wearing a stethoscope filling out a medical form

Doctors call for improved physical health monitoring for people prescribed psychiatric medication

A major new Lancet Commission has called for people taking psychiatric medications - such as antidepressants, antipsychotics, and mood stabilisers - to receive proactive, ongoing physical health monitoring and support.

Close-up of surgical procedure with medical instruments

Obese surgical patients’ medication lifeline can reduce risk

Overweight patients waiting for operations could safely use a particular type of weight-loss treatment to reduce the risk of surgical complications linked to their obesity, a new study reveals.

newborn baby and mother

Women with obesity seeking IVF found to be 47% more likely to conceive naturally after weight loss

Women with obesity who participate in weight loss programmes before starting in vitro fertilisation (IVF) are 47% more likely to conceive naturally than those receiving minimal or no weight loss support, according to the most comprehensive systematic review of the evidence to date.

Using a microscope for cancer research in a lab

Study reveals liver problems may drive DNA build-up in sepsis patients

Researchers at NDM’s Centre for Human Genetics have discovered that cell-free DNA builds up in the blood of patients with sepsis because of impaired liver clearance. These findings show that investigating cell-free DNA could be a powerful tool for monitoring what happens in the body during sepsis.

people enjoying the event

Celebrating 25 years of Oxford’s Graduate-entry Medicine Course

This year marks 25 years since the first cohort of students started on the Graduate Entry medicine course in Oxford – an accelerated programme designed for students with prior degrees in experimental sciences. To mark this milestone, events were held in the afternoon and evening of Saturday 5 July, hosted at St Hilda’s College. Alumni and faculty from across the past 25 years joined to reconnect and reflect on the programme.

A 3D medical illustration of breast cancer

Continuing hormone treatment with aromatase inhibitors beyond five years further reduces the risk of breast cancer recurrence by a quarter in postmenopausal women

Continuing treatment with aromatase inhibitors (a type of hormone therapy) for another five years further reduces the risk of developing secondary breast cancer by over a quarter for certain women. These results from the Early Breast Cancer Trialists’ Collaborative Group (EBCTCG), based at Oxford Population Health, are published in The Lancet.

A female doctor showing a radiograph to a patient

Scientists create first atlas showing cell interaction in lung fibrosis

In a collaborative new study, researchers have developed the first mathematically supported cellular map of lung tissue in idiopathic pulmonary fibrosis and uncovered key immune cell interactions that could explain why lungs fail to repair in this deadly disease with no known cure.

A male doctor examining a boy in Africa

New research highlights need for global action to tackle noma disease

A new paper conducted by the Infectious Disease Data Observatory and the World Health Organization has revealed major gaps in research on noma, a severe and often fatal oral disease affecting children in low-resource settings. The review analysed 366 studies to provide a comprehensive foundation for future research and policy action.

Load More